Intestinal microbiota in short bowel syndrome

Area of Science:

• Pediatric Gastroenterology
• Microbiome Research
• Intestinal Health

Background:

• Short bowel syndrome (SBS) in children leads to significant intestinal loss.
• This loss causes profound alterations in the gut microbiota composition and function.
• These microbial shifts are linked to various complications in pediatric SBS patients.

Purpose of the Study:

• To elucidate the implications of altered gut microbiota in pediatric short bowel syndrome.
• To investigate the impact of dysbiosis on gut function, hepatic cholestasis, and nutritional status.
• To review potential therapeutic strategies for restoring a healthy gut microbial community in SBS.

Main Methods:

• Literature review of studies on pediatric short bowel syndrome and gut microbiota.
• Analysis of research on the relationship between microbial changes and SBS complications.
• Synthesis of information on current and emerging therapies for microbial restoration.

Main Results:

• Intestinal microbiota dysbiosis is a key feature of pediatric SBS.
• Microbiota alterations contribute to impaired gut barrier function, malabsorption, and liver disease (hepatic cholestasis).
• Nutritional deficiencies are exacerbated by altered microbial metabolism and nutrient absorption.

Conclusions:

• Gut microbiota plays a critical role in the pathophysiology of pediatric short bowel syndrome.
• Targeting the microbiome offers a promising avenue for improving outcomes in SBS.
• Further research into microbiome-directed therapies is warranted to optimize care for these children.